BMV:XBI Holdings Information

BMV:XBI is an equity ETF with a total of 155 individual holdings. The top holdings are Apellis Pharmaceuticals stock at 1.79%, Revolution Medicines at 1.65%, Travere Therapeutics at 1.64%, TG Therapeutics at 1.62%, and Arrowhead Pharmaceuticals at 1.48%.

Total Holdings

155

Top 10 Percentage

14.95%

Asset Class

Equity

ETF Category

Health Care

Assets

141.58B

PE Ratio

n/a

Breakdown by Sector

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	APLS	Apellis Pharmaceuticals, Inc.	1.79%	3,754,636
2	RVMD	Revolution Medicines, Inc.	1.65%	942,345
3	TVTX	Travere Therapeutics, Inc.	1.64%	3,171,500
4	TGTX	TG Therapeutics, Inc.	1.62%	3,345,743
5	ARWR	Arrowhead Pharmaceuticals, Inc.	1.48%	1,615,250
6	ALKS	Alkermes plc	1.38%	3,379,473
7	TWST	Twist Bioscience Corporation	1.38%	2,002,595
8	MDGL	Madrigal Pharmaceuticals, Inc.	1.36%	217,438
9	BEAM	Beam Therapeutics Inc.	1.35%	3,598,540
10	CELC	Celcuity Inc.	1.31%	810,778
11	MIRM	Mirum Pharmaceuticals, Inc.	1.30%	1,022,934
12	CYTK	Cytokinetics, Incorporated	1.28%	1,475,048
13	EXEL	Exelixis, Inc.	1.27%	2,247,933
14	PRAX	Praxis Precision Medicines, Inc.	1.24%	315,998
15	NBIX	Neurocrine Biosciences, Inc.	1.23%	724,462
16	KRYS	Krystal Biotech, Inc.	1.23%	368,005
17	APGE	Apogee Therapeutics, Inc.	1.23%	1,256,725
18	CRSP	CRISPR Therapeutics AG	1.20%	1,879,603
19	UTHR	United Therapeutics Corporation	1.19%	172,265
20	NTRA	Natera, Inc.	1.19%	477,366
21	SRRK	Scholar Rock Holding Corporation	1.18%	2,173,458
22	PTGX	Protagonist Therapeutics, Inc.	1.17%	972,832
23	RYTM	Rhythm Pharmaceuticals, Inc.	1.17%	1,042,596
24	KYMR	Kymera Therapeutics, Inc.	1.15%	1,151,307
25	INCY	Incyte Corporation	1.15%	991,507

Showing 25 of 155 holdings

Subscribe to see the full list

Activate Now

As of May 6, 2026